Pot Chl/nacl 0.15/.45% Inj, 1000ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered as an infusion into a vein over a period of time. Your doctor may instruct you on how to self-administer this medication.
Before and after handling the medication, wash your hands thoroughly. Do not use the solution if it appears cloudy, is leaking, or contains particles. Additionally, do not use the solution if it has changed color.
To dispose of used needles and other sharp objects, use a needle/sharp disposal box. Never reuse needles or other items. When the disposal box is full, follow local regulations for proper disposal. If you have any questions or concerns, consult your doctor or pharmacist.
Storage and Disposal
Typically, this medication is administered in a hospital or doctor's office. If you need to store it at home, follow the storage instructions provided by your doctor.
Missed Dose
If you miss a dose, contact your doctor to determine the best course of action.
Lifestyle & Tips
- This medication is administered in a healthcare setting. No specific lifestyle modifications are typically required by the patient during administration, but underlying conditions requiring the fluid may necessitate dietary or activity changes.
- Report any unusual symptoms or discomfort during the infusion (e.g., pain at injection site, swelling, shortness of breath, dizziness, muscle weakness).
Available Forms & Alternatives
Available Strengths:
- Potassium Cl 2meq/ml Inj 30ml
- Kcl/d5w/nacl 0.15/0.9 Inj , 1000ml
- Kcl/d5w/nacl .15/.45% Inj, 1000ml
- Potassium Cl 2meq/ml Inj 20ml
- Potassium Cl 2meq/ml Inj 10ml
- Potassium Cl 2meq/ml Inj 20ml
- Pot Chl/nacl 0.15/.45% Inj, 1000ml
- Kcl/d5w/lr 0.15% Inj, 1000ml
- Pot Chloride 20meq Inj, 100ml
- Kcl/d5w/nacl 0.3/0.45 Inj, 1000ml
- Kcl/d5w/nacl .075/.45 Inj, 1000ml
- Kcl/d5w/nacl 0.15/0.2 Inj, 1000ml
- Pot Chl/dextrose 5%/nacl0.45% Inj
- Potassium Chloride ER 8meq Tablets
- Potassium Cl 10meq ER Tablets
- Potassium Chloride ER 8meq ER Tabs
- Potassium Cl 10meq ER Capsules
- Potassium Chlor 10% Liq(20meq/15ml)
- Potassium Chlor 20% Liq(40meq/15ml)
- Potassium Cl Micro 10meq ER Tabs
- Pot Chloride 8meq CR Capsules
- Potassium Chloride 20meq Powder Pkt
- Potassium Cl Micro 10meq ER Tabs
- Potassium Cit ER 1620mg (15meq) Tab
- Potassium Cl Micro 10meq ER Tabs
- Potassium Chl 40meq Inj, 100ml
- Potassium Chloride 10meq Inj, 50ml
- Potassium Chloride 20meq Inj, 50ml
- Potassium Chloride 10meq ER Tablets
- Kcl/d5w/lact 20meq/l Inj, 1000ml
- Potassium Chloride 20meq ER Tablets
- Potassium Cl 20meq ER Tablets
- Potassium Chloride 20meqpowder Pkt
- Potassium Cl 2meq/ml Inj 250ml
- Potassium Cl 2meq/ml Inj 50ml
- Potassium Chl 10meq Inj,100ml
- Pot Chl/nacl 40meq/l Inj, 1000ml
- Pot Chl/d5w 20meq/l Inj, 1000ml
- Pot Chl/d5w 10meq/l Inj, 1000ml
- Potassium Chlor/nacl 20meq/l Inj
- Potassium Chloride 15meq ER Tabs
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following signs or symptoms, contact your doctor or seek medical attention immediately:
Allergic reaction symptoms, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of fluid and electrolyte problems, including:
+ Mood changes
+ Confusion
+ Muscle pain or weakness
+ Fast or abnormal heartbeat
+ Severe dizziness or passing out
+ Increased thirst
+ Seizures
+ Feeling very tired or weak
+ Decreased appetite
+ Unable to pass urine or changes in urine production
+ Dry mouth
+ Dry eyes
+ Severe upset stomach or vomiting
Signs of skin infection, such as:
+ Oozing
+ Heat
+ Swelling
+ Redness
+ Pain
Swelling, warmth, numbness, color changes, or pain in a leg or arm
Chest pain or pressure
Fever
Shortness of breath
Sudden weight gain
Swelling in the arms or legs
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. If you notice any of the following side effects or any other unusual symptoms, contact your doctor for advice:
Irritation or swelling at the injection site
* Pain at the injection site
Reporting Side Effects
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Swelling in your hands, ankles, or feet (signs of fluid overload)
- Difficulty breathing or shortness of breath
- Rapid weight gain
- Muscle weakness or cramps
- Numbness or tingling sensations
- Irregular heartbeat or palpitations
- Confusion or unusual drowsiness
- Severe thirst or dry mouth
- Headache or nausea
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This is crucial to avoid potential interactions between this medication and other substances.
Any existing health problems you have, as they may affect the safety and efficacy of this medication.
To ensure your safety, it is vital to:
Discuss all your medications and health problems with your doctor and pharmacist to verify that it is safe to take this medication in conjunction with your other treatments.
* Avoid starting, stopping, or changing the dosage of any medication without first consulting your doctor. This will help prevent potential interactions and ensure the safe use of this medication.
Precautions & Cautions
If your medication contains potassium, consult your doctor before using any salt substitutes or products that also contain potassium.
If your medication contains dextrose and you have diabetes (high blood sugar), discuss this with your doctor to ensure safe use.
Regular blood tests will be necessary, as directed by your doctor, to monitor your condition. Be sure to follow your doctor's instructions and discuss any concerns or questions you may have.
When administering this medication to newborns, exercise caution, as the risk of side effects may be increased in this age group.
If you are pregnant, planning to become pregnant, or are breastfeeding, inform your doctor. It is crucial to discuss the potential benefits and risks of this medication to both you and your baby, allowing for an informed decision about its use.
Overdose Information
Overdose Symptoms:
- Hyperkalemia (high potassium): Muscle weakness, paresthesias, flaccid paralysis, bradycardia, hypotension, cardiac arrhythmias (peaked T waves, widened QRS).
- Hypernatremia (high sodium): Thirst, lethargy, confusion, seizures, coma.
- Fluid Overload: Edema, dyspnea, crackles on lung auscultation, jugular venous distension, hypertension.
What to Do:
Immediately stop the infusion. Management is supportive and depends on the specific electrolyte imbalance and severity. This may include diuretics for fluid overload, calcium gluconate for cardiac protection in hyperkalemia, insulin/glucose for potassium shift, or dialysis in severe cases. Call 1-800-222-1222 (Poison Control) or seek immediate medical attention.
Drug Interactions
Contraindicated Interactions
- Hyperkalemia
- Hypernatremia
- Severe renal impairment (anuria, oliguria) without dialysis
- Addison's disease (risk of hyperkalemia)
- Acute dehydration (if hypotonic solution is inappropriate)
Major Interactions
- Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene): Increased risk of severe hyperkalemia.
- ACE inhibitors (e.g., lisinopril, enalapril): Increased risk of hyperkalemia.
- Angiotensin Receptor Blockers (ARBs) (e.g., valsartan, losartan): Increased risk of hyperkalemia.
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs): May impair renal potassium excretion, increasing hyperkalemia risk.
- Cyclosporine, Tacrolimus: Increased risk of hyperkalemia.
- Digoxin: Hyperkalemia can antagonize digoxin effects; hypokalemia can potentiate digoxin toxicity. Careful monitoring required.
- Corticosteroids: May cause sodium and fluid retention, increasing risk of hypernatremia or fluid overload.
Moderate Interactions
- Other diuretics (e.g., loop diuretics, thiazide diuretics): May alter sodium and potassium balance, requiring careful monitoring.
- Insulin: Can cause intracellular shift of potassium, potentially leading to hypokalemia if not balanced by potassium intake.
- Beta-blockers: May impair cellular uptake of potassium, increasing serum potassium levels.
Minor Interactions
- None specifically for this combination, as interactions are primarily related to electrolyte balance.
Monitoring
Baseline Monitoring
Rationale: To establish baseline electrolyte status and identify pre-existing imbalances (e.g., hyperkalemia, hyponatremia) that may contraindicate or require adjustment of therapy.
Timing: Prior to initiation of infusion.
Rationale: To assess kidney's ability to excrete electrolytes and fluid, which directly impacts dosing and risk of accumulation.
Timing: Prior to initiation of infusion.
Rationale: To assess hydration status and identify signs of fluid overload or dehydration.
Timing: Prior to initiation of infusion.
Rationale: Especially important if patient has pre-existing cardiac conditions or is at risk for hyperkalemia, as potassium imbalances can cause life-threatening arrhythmias.
Timing: Prior to initiation, particularly if rapid infusion or high potassium dose is anticipated.
Routine Monitoring
Frequency: Every 4-6 hours initially, then daily or as clinically indicated based on patient stability and infusion rate.
Target: Sodium: 135-145 mEq/L; Potassium: 3.5-5.0 mEq/L; Chloride: 98-107 mEq/L
Action Threshold: Values outside normal range, especially potassium >5.5 mEq/L or <3.0 mEq/L, or sodium <130 mEq/L or >150 mEq/L. Requires immediate assessment and potential adjustment of infusion.
Frequency: Daily or every other day, or as clinically indicated.
Target: Within patient's baseline or normal limits.
Action Threshold: Significant increase in BUN/Creatinine, indicating worsening renal function, requires re-evaluation of fluid and electrolyte management.
Frequency: Every 4-8 hours or more frequently as clinically indicated.
Target: Stable vital signs, adequate urine output (>0.5 mL/kg/hr), no new or worsening edema, clear lung sounds, stable weight.
Action Threshold: Signs of fluid overload (e.g., crackles, dyspnea, increasing edema, rapid weight gain) or dehydration (e.g., orthostasis, poor skin turgor, decreased urine output).
Frequency: Continuous monitoring if rapid potassium infusion or significant electrolyte abnormalities are present; otherwise, daily or as clinically indicated.
Target: Normal sinus rhythm, absence of peaked T waves, widened QRS, or other signs of hyperkalemia/hypokalemia.
Action Threshold: Any new arrhythmias or ECG changes suggestive of electrolyte imbalance.
Symptom Monitoring
- Signs of hyperkalemia: Muscle weakness, paresthesias, flaccid paralysis, bradycardia, hypotension, cardiac arrhythmias (peaked T waves, widened QRS, absent P waves).
- Signs of hypokalemia: Muscle weakness, cramps, fatigue, constipation, ileus, cardiac arrhythmias (flattened T waves, U waves, ST depression).
- Signs of hypernatremia: Thirst, lethargy, confusion, seizures, coma, dry mucous membranes.
- Signs of hyponatremia: Headache, nausea, vomiting, lethargy, confusion, seizures, coma.
- Signs of fluid overload: Dyspnea, orthopnea, cough, crackles on lung auscultation, peripheral edema, jugular venous distension, rapid weight gain.
- Signs of dehydration: Thirst, dry mucous membranes, decreased skin turgor, decreased urine output, dizziness, orthostatic hypotension.
Special Patient Groups
Pregnancy
Potassium and sodium are essential electrolytes. This solution should be used during pregnancy only if clearly needed and the potential benefits outweigh the potential risks. Careful monitoring of fluid and electrolyte balance is crucial, as pregnancy can alter fluid dynamics and renal function.
Trimester-Specific Risks:
Lactation
Potassium and sodium are normal components of breast milk. Administration of this solution is generally considered safe during lactation, as it replenishes essential electrolytes and is unlikely to cause adverse effects in the infant when administered appropriately to the mother.
Pediatric Use
Use with extreme caution. Pediatric patients, especially neonates and infants, have immature renal function and smaller fluid compartments, making them highly susceptible to fluid overload and electrolyte imbalances (hyperkalemia, hypernatremia, hyponatremia). Dosing must be highly individualized based on weight, age, and clinical status, with frequent and meticulous monitoring of fluid intake/output, daily weight, and serum electrolytes.
Geriatric Use
Use with caution. Elderly patients are more likely to have impaired renal function, cardiac disease, and other comorbidities that predispose them to fluid overload, hyperkalemia, or other electrolyte disturbances. Start with lower infusion rates and monitor fluid status, renal function, and electrolytes frequently. Avoid rapid infusions.
Clinical Information
Clinical Pearls
- Always verify patient's baseline electrolyte levels and renal function before initiating infusion.
- Never administer potassium chloride as a rapid IV push; always dilute and infuse slowly to prevent fatal arrhythmias.
- Monitor ECG continuously when administering potassium at higher rates or to patients at risk for hyperkalemia.
- Assess fluid status frequently (daily weights, I&O, vital signs, lung sounds, edema) to prevent fluid overload or dehydration.
- This solution is hypotonic (0.45% NaCl) and is primarily used for maintenance fluid therapy or to replace free water deficits, not for rapid volume expansion in hypovolemic shock.
- Be aware of drug interactions, especially with medications that affect potassium or sodium levels (e.g., ACE inhibitors, ARBs, potassium-sparing diuretics).
- In patients with significant renal impairment, potassium-containing fluids are generally contraindicated or require extreme caution and close monitoring.
Alternative Therapies
- Oral rehydration solutions (for mild dehydration/electrolyte imbalance)
- Other intravenous crystalloid solutions (e.g., 0.9% NaCl, Lactated Ringer's, D5W) depending on specific fluid and electrolyte needs.
- Specific electrolyte supplements (e.g., oral potassium chloride, sodium chloride tablets) for less acute or chronic imbalances.